Literature DB >> 11882909

New diagnostic tool for differentiation of idiopathic hypereosinophilic syndrome (HES) and secondary eosinophilic states.

T Berki1, M Dávid, B Bóné, H Losonczy, J Vass, P Németh.   

Abstract

The hypereosinophilic syndrome (HES) is a very rare disease, characterized by persistent eosinophilia with tissue involvement and organ dysfunction which often precedes a subsequent T cell lymphoma. Interleukin-5 secreted by a T lymphocyte subpopulation has been described in previous reports as the most important factor responsible for the prolonged lifespan of the eosinophils. The goal of the present study was to describe a fast, simple diagnostic method for the differentiation of HES and secondary eosinophilic states. Beside the surface marker analysis of peripheral blood mononuclear cells (PBMC) we measured surface bound IgE molecules on lymphocytes and eosinophil cells, intracellular cytokines (IL-5, INFgamma) in CD4+ lymphocytes and eosinophil major basic protein (MBP) in eosinophils using flow cytometric detection method. The appearance of an IL-5 producing cell population with a decreased number of INFgamma positive lymphocytes was characteristic for the blood samples of HES patients. Predominance of Th2 cells with the appearance of a CD8+/CD3 /CD56+ cell population was restricted for the HES cases and could not be detected in secondary eosinophilic individuals. Our flow cytometric cytokine detection method (with parallel cell surface marker analysis) does not require cell separation or long term cell culture steps previously described for the detection of IL-5 producing cells. Therefore it seems to be a more appropriate approach for the differential diagnosis of primary and secondary eosinophilic states.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11882909     DOI: 10.1007/bf03032386

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  31 in total

Review 1.  The immunobiology of eosinophils.

Authors:  P F Weller
Journal:  N Engl J Med       Date:  1991-04-18       Impact factor: 91.245

Review 2.  Human eosinophils: their accumulation, activation and fate.

Authors:  G M Walsh
Journal:  Br J Haematol       Date:  1997-06       Impact factor: 6.998

3.  Hypereosinophilic syndrome and myocardial infarction in a 15-year-old.

Authors:  A E Rauch; K M Amyot; H G Dunn; B Ng; G Wilner
Journal:  Pediatr Pathol Lab Med       Date:  1997 May-Jun

4.  Distinction of eosinophilic leukaemia from idiopathic hypereosinophilic syndrome by analysis of Wilms' tumour gene expression.

Authors:  H D Menssen; H J Renkl; H Rieder; S Bartelt; A Schmidt; M Notter; E Thiel
Journal:  Br J Haematol       Date:  1998-05       Impact factor: 6.998

5.  A flow cytometric method for the detection of intracellular basic proteins in unseparated peripheral blood and bone marrow eosinophils.

Authors:  N Krug; A M Thurau; P Lackie; J Baier; G Schultze-Werninghaus; C H Rieger; U Schauer
Journal:  J Immunol Methods       Date:  1996-04-19       Impact factor: 2.303

Review 6.  Chronic eosinophilic leukemia and hypereosinophilic syndromes. Proposal for classification, literature review, and report of a case with a unique chromosomal abnormality.

Authors:  J W Oliver; I Deol; D L Morgan; V S Tonk
Journal:  Cancer Genet Cytogenet       Date:  1998-12

7.  Production and flow cytometric application of a monoclonal anti-glucocorticoid receptor antibody.

Authors:  T Berki; G Kumánovics; A Kumánovics; A Falus; E Ujhelyi; P Németh
Journal:  J Immunol Methods       Date:  1998-05-01       Impact factor: 2.303

8.  Interleukin-5 mRNA levels in blood and bone marrow mononuclear cells from patients with the idiopathic hypereosinophilic syndrome.

Authors:  T Satoh; L Sun; M S Li; C J Spry
Journal:  Immunology       Date:  1994-10       Impact factor: 7.397

9.  A case of hypereosinophilic syndrome is associated with the expansion of a CD3-CD4+ T-cell population able to secrete large amounts of interleukin-5.

Authors:  D Brugnoni; P Airó; G Rossi; A Bettinardi; H U Simon; L Garza; C Tosoni; R Cattaneo; K Blaser; A Tucci
Journal:  Blood       Date:  1996-02-15       Impact factor: 22.113

10.  Interleukin 5 and phenotypically altered eosinophils in the blood of patients with the idiopathic hypereosinophilic syndrome.

Authors:  W F Owen; M E Rothenberg; J Petersen; P F Weller; D Silberstein; A L Sheffer; R L Stevens; R J Soberman; K F Austen
Journal:  J Exp Med       Date:  1989-07-01       Impact factor: 14.307

View more
  2 in total

1.  Peripheral T-cell lymphoma-unspecified (PTCL-U) presenting with hypereosinophilic syndrome and pleural effusions.

Authors:  Won Choi; Yeon Hee Park; Kwang Hyun Paik; Yoon Hwan Chang; Seung-Sook Lee; Baek-Yeol Ryoo; Sung Hyun Yang
Journal:  Korean J Intern Med       Date:  2006-03       Impact factor: 2.884

Review 2.  [Hypereosinophilic syndrome and Churg-Strauss syndrome: is it clinically relevant to differentiate these syndromes?].

Authors:  B Hellmich; K Holl-Ulrich; H Merz; W L Gross
Journal:  Internist (Berl)       Date:  2008-03       Impact factor: 0.743

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.